EW:NYSE
Edwards Lifesciences Corp
US$ 107.15
arrow_upward
+1.19%(+1.26) Siku 1
US$ 106.50
arrow_downward
-0.61% (-0.65)bedtimeBaada ya saa
Imefungwa: 13 Nov, 16:00:04 GMT -5 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya EW...
Fungua
US$ 106.10
Juu
US$ 107.69
Chini
US$ 106.01
Mtaji wa soko
61.61B
Wastani wa kiasi cha mauzo
4.51M
Kiasi cha mauzo ya hisa
3.82M
Uwiano wa bei ya hisa na mapato kwa kila hisa
60.75
Juu kwa wiki 52
US$ 107.69
Chini kwa wiki 52
US$ 74.66
EPS
US$ 1.76
Beta
0.85
Hisa za wawekezaji
575.00M
Idadi ya wafanyakazi
elfu 16
Fungua
US$ 106.10
Juu
US$ 107.69
Chini
US$ 106.01
Mtaji wa soko
61.61B
Wastani wa kiasi cha mauzo
4.51M
Kiasi cha mauzo ya hisa
3.82M
Uwiano wa bei ya hisa na mapato kwa kila hisa
60.75
Juu kwa wiki 52
US$ 107.69
Chini kwa wiki 52
US$ 74.66
EPS
US$ 1.76
Beta
0.85
Hisa za wawekezaji
575.00M
Idadi ya wafanyakazi
elfu 16
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Traders Union
·
saa 21 zilizopita
MarketWise: Edwards Lifesciences revenue climbs 10.5 percent, earnings surge 19 percent
News Corp
·
siku 1 iliyopita
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day
Zacks
·
siku 1 iliyopita
Top Stock Reports for Visa, ExxonMobil & Pfizer
Wasifu
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
Kuhusu Edwards Lifesciences Corp
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 16
Lilianzishwa1958
Makao makuuIrvine, California, Marekani
SektaHealth Care
Sekta-
Tovutiedwards.com